Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease

Neurology

Volumn 80, Issue 8, 2013, Pages 743-746

  Stüwe, Sven H ^a   Goetze, Oliver ^b,c   Lukas, Carsten ^a   Klotz, Peter ^a   Hoffmann, Rainer ^a   Banasch, Matthias ^b   Orth, Michael ^d   Schmidt, Wolfgang E ^b   Gold, Ralf ^a   Saft, Carsten ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; METHIONINE C 13; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE MUTATION; HEPATIC MITOCHONDRIAL DYSFUNCTION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MALE; PRIORITY JOURNAL; UNIFIED HUNTINGTON DISEASE RATING SCALE;

ADULT; BREATH TESTS; CARBON RADIOISOTOPES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HUNTINGTON DISEASE; LIVER DISEASES; MALE; METHIONINE; MIDDLE AGED; MITOCHONDRIA; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 84876249939     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318282514e     Document Type: Article

References (10)

1. Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A. Huntington's disease: the current state of research with peripheral tissues. Exp Neurol 2009;219:385-397.
2. Quintanilla RA, Johnson GV. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res Bull 2009;80:242-247.
3. Stuwe SH, Goetze O, Arning L, et al. Hepatic mitochondrial dysfunction in Friedreich ataxia. BMC Neurol 2011; 11:145.
4. Armuzzi A, Marcoccia S, Zocco MA, et al. Non-invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol 2000;35:650-653.
5. Banasch M, Frank J, Serova K, et al. Impact of antiretroviral treatment on (13) C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med 2010;12:40-45.
6. Saft C, Andrich J, Meisel NM, Przuntek H, Muller T. Assessment of simple movements reflects impairment in Huntington's disease. Mov Disord 2006;21:1208-1212.
7. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801.
8. Stout JC, Paulsen JS, Queller S, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011; 25:1-14.
9. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature 2010;464:529-535.
10. Taherzadeh-Fard E, Saft C, Akkad DA, et al. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 2011;6:32.